Related Experiment Video
Updated: Feb 14, 2026

Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain
Published on: July 29, 2022
MAD2-p31comet axis deficiency reduces cell proliferation, migration and sensitivity of microtubule-interfering agents
Dang Wu1, Lepeng Wang2, Yanhong Yang1
1Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
Abstract:
Mitotic arrest deficient-like-1 (MAD2, also known as MAD2L1) is thought to be an important spindle assembly checkpoint protein, which ensures accurate chromosome segregation and is closely associated with poor prognosis in many cancer. As a MAD2 binding protein, p31comet counteracts the function of MAD2 and leads to mitotic checkpoint silence. In this study, we explore the function of MAD2-p31comet axis in malignant glioma cells. Our results showed that disruption of MAD2-p31comet axis by MAD2 knockdown or p31comet overexpression suppressed cell proliferation, survival and migration of glioma, indicating that MAD2-p31comet axis is required for maintaining glioma cells malignancy. It is noted that MAD2 depletion or p31comet overexpression reduced the sensitivity of glioma cells to microtubule-interfering agents paclitaxel and vinblastine, providing clinical guidance for application of such drugs. Taken together, our findings suggest that MAD2-p31comet axis may serve as a potential therapeutic target for glioma.
Insights
The MAD2-p31comet axis is crucial for malignant glioma growth and survival. Targeting this axis may offer new therapeutic strategies for glioma patients, potentially improving responses to chemotherapy.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Background:
- Mitotic arrest deficient-like-1 (MAD2) is a key spindle assembly checkpoint protein vital for accurate chromosome segregation.
- MAD2 is associated with poor prognosis in various cancers, including malignant glioma.
- p31comet, a MAD2-binding protein, counteracts MAD2 function, leading to mitotic checkpoint silencing.
Purpose of the Study:
- To investigate the functional role of the MAD2-p31comet axis in malignant glioma cells.
- To determine the therapeutic potential of targeting the MAD2-p31comet axis in glioma.
Main Methods:
- MAD2 knockdown and p31comet overexpression were employed in glioma cell models.
- Cell proliferation, survival, and migration assays were conducted.
- Sensitivity to microtubule-interfering agents (paclitaxel, vinblastine) was assessed.
Main Results:
- Disruption of the MAD2-p31comet axis suppressed glioma cell proliferation, survival, and migration.
- MAD2 depletion or p31comet overexpression reduced glioma cell sensitivity to paclitaxel and vinblastine.
- The MAD2-p31comet axis is essential for maintaining glioma cell malignancy.
Conclusions:
- The MAD2-p31comet axis plays a critical role in malignant glioma progression.
- Targeting the MAD2-p31comet axis presents a potential therapeutic strategy for glioma.
- Findings provide clinical guidance for the application of microtubule-interfering agents in glioma treatment.
More Related Videos
09:57In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
06:51Real-Time Monitoring of Human Glioma Cell Migration on Dorsal Root Ganglion Axon-Oligodendrocyte Co-Cultures
Published on: December 13, 2019
Related Concept Videos
Microtubules
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Redox Titration: Other Oxidizing and Reducing Agents
Cell Migration
Cell Migration
Microtubules in Cell Motility